Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Amphastar Pharmaceuticals (29A.F) Q2 2026 Earnings
29A.F
7
May
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
0.36
0.51
0.66
0.81
Details
Expected EPS
0.6012321123900001
Actual EPS
0.3581214
Surprise EPS
-0.24
Surprise Percent
+40.44%
Description
Amphastar Pharmaceuticals (29A.F) has reported earnings of 0.3581214 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login